CD4 and cancer: Exosomes carrying biologically active CD39 and CD73 were isolated from the plasma of normal controls and were enriched in the cancer patients’ body fluids, suggesting that exosomes derived from CD73+ tumor cells in body fluids of cancer patients may be an especially rich source of CD73 enabling CD4+CD39+ human Treg to produce ADO.